← Eichor
Study identifier: NCT01799915 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Natural History Study of Synucleinopathies

Condition: Patients With Synucleinopathies · Neurogenic Orthostatic Hypotension · Pure Autonomic Failure  ·  Sponsor: NYU Langone Health

PhaseN/A
Planned participants800
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Synucleinopathies are a group of rare diseases associated with worsening neurological deficits and the abnormal accumulation of the protein α-synuclein in the nervous system. Onset is usually in late adulthood at age 50 or older. Usually, synucleinopathies present clinically with slowness of movement, coordination difficulties or mild cognitive impairment. Development of these features indicates that abnormal alpha-synuclein deposits have destroyed key areas of the brain involved in the control of movement or cognition. Patients with synucleinopathies and signs of CNS-deficits are frequently diagnosed with Parkinson disease (PD), dementia with Lewy bodies (DLB) or multiple system atrophy (MSA). However, accumulation of alpha-synuclein and death of nerve cells can also begin outside the brain in the autonomic nerves. In such cases, syncucleinopathies present first with symptoms of autonomic impairment (unexplained constipation, urinary difficulties, and sexual dysfunction). In rare cases, hypotension on standing (a disorder known as orthostatic hypotension) may be the only clinical finding. This "pre-motor" autonomic stage suggests that the disease process may not yet have spread to the brain. After a variable period of time, but usually within 5-years, most patients with abnormally low blood pressure on standing develop cognitive or motor abnormalities. This stepwise evolution indicates that the disease spreads from the body to the brain. Another indication of this spread i…

This description comes directly from the study's public registry record.

Talk to the study team

Horacio Kaufmann, MD  ·  212-263-7225  ·  horacio.kaufmann@nyulangone.org

Grace Nkrumah  ·  212-263-7225  ·  grace.nkrumah@nyulangone.org

Always discuss trial participation with your own doctor first.

Locations (8)

Beth Israel Deaconess Medical CenterBoston, Massachusetts, United StatesRecruiting
University of MichiganAnn Arbor, Michigan, United StatesRecruiting
Mayo ClinicRochester, Minnesota, United StatesRecruiting
NYU Medical CenterNew York, New York, United StatesRecruiting
Vanderbilt UniveristyNashville, Tennessee, United StatesRecruiting
FLENI - Fundación para la Lucha contras las Enfermedades NeurológicasBuenos Aires, ArgentinaRecruiting
Seoul National University HospitalSeoul, South KoreaRecruiting
BioCruces Research Institute - Hospital Universitario de CrucesBilbao, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT01799915